Cost-effectiveness of fecal calprotectin used in primary care in the diagnosis of IBD
The use of Fecal Calprotectin test in primary care reduced the time to IBD diagnosis by 40 days, compared with blood testing alone. Read more
Cost-effectiveness of fecal calprotectin used in primary care in the diagnosis of IBD
The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review
Diet may be a successful part of the treatment plan for improving outcome in patients with inflammatory bowel disease (IBD). Read more
Meet Dr. Greg Rosenfeld
Dr. Rosenfeld is a co-founder of The IBD Centre of BC and leads the operational push behind just about every aspect of the Centre. Read more
A Qualitative Research for Defining Meaningful Attributes for the Treatment of IBD from the Patient Perspective
Through the identification of the ten most relevant attributes that influence patient decision making for IBD treatments, we developed a descriptive framework that should be considered by physicians when discussing Read more
Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease
A significant proportion of IBD patients suffer from depression and/or anxiety. The rates of these mental illnesses would justify screening and referral for psychiatric treatment in clinics treating this population. Read more
Fecal Calprotectin in Pregnancy
Active IBD is associated with adverse pregnancy outcomes, necessitating close monitoring of these higher risk pregnancies. Read more
IBDoc Canadian User Performance Evaluation
The IBDoc® Test Kit that empowers patients by providing an easy to use therapy monitoring home testing system for IBD Patients. Read more